Richard Sidwell
10Patents
2h-index
2Co-inventors
36Inventor score
Filing activity: Sep 7, 2012 → Sep 7, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9132096B1 | Abuse resistant pharmaceutical compositions | Human Necessities | 8 | Active |
| US8992973B2 | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | Human Necessities | 4 | Active |
| US10092559B2 | Abuse resistant pharmaceutical compositions | Human Necessities | 1 | Active |
| US9713611B2 | Abuse resistant pharmaceutical compositions | Human Necessities | 1 | Active |
| US9486451B2 | Abuse resistant pharmaceutical compositions | Human Necessities | 1 | Active |
| US9308177B2 | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | Human Necessities | 0 | Active |
| US9452163B2 | Abuse resistant pharmaceutical compositions | Human Necessities | 0 | Active |
| US10960000B2 | Abuse resistant pharmaceutical compositions | Human Necessities | 0 | Active |
| US10213389B2 | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | Human Necessities | 0 | Active |
| US9463166B2 | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.